Bioventix (BVXP) Competitors

Oxford Biomedica (LON:OXB) and Bioventix (LON:BVXP) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, media sentiment, risk, dividends and earnings.

Which has higher valuation and earnings, OXB or BVXP?

Bioventix has lower revenue, but higher earnings than Oxford Biomedica. Oxford Biomedica is trading at a lower price-to-earnings ratio than Bioventix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oxford Biomedica	£98.31M	5.02	-£143.51M	-£134.59	-3.45
Bioventix	£13.65M	10.09	£8.12M	£154.62	17.01

Is OXB or BVXP more profitable?

Bioventix has a net margin of 59.51% compared to Oxford Biomedica's net margin of -145.98%. Bioventix's return on equity of 69.09% beat Oxford Biomedica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oxford Biomedica	-145.98%	-202.50%	-12.67%
Bioventix	59.51%	69.09%	54.07%

Which has more volatility & risk, OXB or BVXP?

Oxford Biomedica has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, Bioventix has a beta of 0.35, meaning that its share price is 65% less volatile than the S&P 500.

Do analysts prefer OXB or BVXP?

Oxford Biomedica presently has a consensus target price of GBX 390, suggesting a potential downside of 16.04%. Given Oxford Biomedica's stronger consensus rating and higher probable upside, equities analysts clearly believe Oxford Biomedica is more favorable than Bioventix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oxford Biomedica	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Bioventix	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Do institutionals and insiders believe in OXB or BVXP?

64.1% of Oxford Biomedica shares are held by institutional investors. Comparatively, 62.3% of Bioventix shares are held by institutional investors. 21.2% of Oxford Biomedica shares are held by insiders. Comparatively, 8.0% of Bioventix shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Does the media refer more to OXB or BVXP?

In the previous week, Oxford Biomedica had 2 more articles in the media than Bioventix. MarketBeat recorded 2 mentions for Oxford Biomedica and 0 mentions for Bioventix. Bioventix's average media sentiment score of 1.05 beat Oxford Biomedica's score of 0.26 indicating that Bioventix is being referred to more favorably in the news media.

Company	Overall Sentiment
Oxford Biomedica	Neutral
Bioventix	Positive

Summary

Bioventix beats Oxford Biomedica on 8 of the 15 factors compared between the two stocks.